Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acid.
Saved in:
| Title: | Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acid. |
|---|---|
| Authors: | Fenn, J1,2 (AUTHOR) jfenn@ic.ac.uk, Ridgley, L A1 (AUTHOR), White, A3 (AUTHOR), Sarfas, C3 (AUTHOR), Dennis, M3 (AUTHOR), Dalgleish, A1 (AUTHOR), Reljic, R1 (AUTHOR), Sharpe, S3 (AUTHOR), Bodman-Smith, M1 (AUTHOR) |
| Source: | Clinical & Experimental Immunology. Jun2022, Vol. 208 Issue 3, p301-315. 15p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 160116886 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2<superscript>+</superscript> T cells compared with the aminobisphosphonate drug zoledronic acid. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Fenn%2C+J%22">Fenn, J</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> jfenn@ic.ac.uk</i><br /><searchLink fieldCode="AR" term="%22Ridgley%2C+L+A%22">Ridgley, L A</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22White%2C+A%22">White, A</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sarfas%2C+C%22">Sarfas, C</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dennis%2C+M%22">Dennis, M</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dalgleish%2C+A%22">Dalgleish, A</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Reljic%2C+R%22">Reljic, R</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sharpe%2C+S%22">Sharpe, S</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bodman-Smith%2C+M%22">Bodman-Smith, M</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Clinical+%26+Experimental+Immunology%22">Clinical & Experimental Immunology</searchLink>. Jun2022, Vol. 208 Issue 3, p301-315. 15p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=160116886 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/cei/uxac032 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 15 StartPage: 301 Titles: – TitleFull: Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acid. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fenn, J – PersonEntity: Name: NameFull: Ridgley, L A – PersonEntity: Name: NameFull: White, A – PersonEntity: Name: NameFull: Sarfas, C – PersonEntity: Name: NameFull: Dennis, M – PersonEntity: Name: NameFull: Dalgleish, A – PersonEntity: Name: NameFull: Reljic, R – PersonEntity: Name: NameFull: Sharpe, S – PersonEntity: Name: NameFull: Bodman-Smith, M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: Jun2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 00099104 Numbering: – Type: volume Value: 208 – Type: issue Value: 3 Titles: – TitleFull: Clinical & Experimental Immunology Type: main |
| ResultId | 1 |
